
Broad-Based Technical Strength Lifts Hemo Organic Ltd to 52-Week High of Rs 24.42
2026-07-14 09:45:49Surging to a fresh 52-week high of Rs 24.42 on 14 Jul 2026, Hemo Organic Ltd has demonstrated remarkable price momentum, outperforming its sector by 4.99% in a single session and extending gains over two consecutive days for a total return of 10.2%. This rally comes despite a broadly negative market backdrop, underscoring the stock’s technical resilience.
Read full news article
Broad-Based Technical Strength Lifts Hemo Organic Ltd to 52-Week High of Rs 23.26
2026-07-13 09:54:48From a 52-week low of Rs 8.08 to a fresh high of Rs 23.26 on 13 Jul 2026, Hemo Organic Ltd has surged an impressive 144% over the past year, significantly outpacing the Sensex’s decline of 6.4%. This milestone caps a sustained rally fuelled by a confluence of bullish technical indicators and robust price momentum.
Read full news articleAre Hemo Organic Ltd latest results good or bad?
2026-06-03 19:12:51Hemo Organic Ltd's latest financial results for Q4 FY26 reflect significant operational challenges. The company reported net sales of ₹0.93 crores, marking a return to revenue generation after three consecutive quarters of zero sales. However, this figure represents a substantial year-on-year decline of 61.41% from the previous year, indicating a severe contraction in business activity. The company faced a net loss of ₹0.51 crores, a stark contrast to the profit of ₹0.37 crores reported in the same quarter last year. This loss was accompanied by an operating margin of -31.18%, a notable decline from the positive margin of 5.81% achieved in Q4 FY25. The widening losses and negative margins underscore ongoing operational inefficiencies and challenges in sustaining profitability. Hemo Organic's balance sheet shows a negative book value of ₹-0.44 per share, reflecting complete equity erosion and raising conce...
Read full news article
Hemo Organic Q4 FY26: Steep Losses Mount as Revenue Collapses 61% - Survival Questions Intensify
2026-06-02 18:36:32Hemo Organic Ltd., a micro-cap trading and distribution company with a market capitalisation of just ₹7.00 crores, reported deeply troubling results for Q4 FY26 that underscore mounting existential challenges. The company posted a net loss of ₹0.51 crores in the March 2026 quarter, a dramatic reversal from a profit of ₹0.37 crores in the year-ago period. Revenue collapsed by 61.41% year-on-year to just ₹0.93 crores, whilst the company's balance sheet remains mired in negative net worth territory at ₹-0.15 crores.
Read full news articleIntimation Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015
04-Aug-2026 | Source : BSEAppointment of Secretarial Auditor and Internal Auditor
Board Meeting Outcome for For The Meeting To Be Held Today I.E. 04Th August 2026
04-Aug-2026 | Source : BSEPursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we hereby inform you that meeting of the Board of Directors of the Company in their meeting held today i.e. 04th August 2026 at the Registered Office of the Company which commenced at 5:00 P.M. and concluded at 6:00 P.M. inter alia has considered and approved: a) Appointment of M/s. Jitendra Parmer & Associates Practicing Company Secretaries Ahmedabad (FRN: S2023GJ903900 Peer Review Certificate No. 3523/2023) (Membership No.: FCS - 11336) as Secretarial Auditor of the Company to conduct Secretarial Audit for the financial Year 2025-26. b) Appointment of M/s. Umesh Khese & Co. Chartered Accountant Ahmedabad as the Internal Auditor for the financial year 2026-27.
Announcement under Regulation 30 (LODR)-Newspaper Publication
16-Jul-2026 | Source : BSESubmission of Newspaper Advertisement of extract of Un-audited financials results for the quarter ended on 30th June 2026
Corporate Actions
No Upcoming Board Meetings
No Dividend history available
No Splits history available
No Bonus history available
No Rights history available






